Clinical trial
A Multicenter, Open-label Study to Evaluate 52 Weeks Long Term Efficacy and Safety of K-924 in Patients With Hypercholesterolemia Who Were Treated With Pitavastatin 2 mg or 4 mg.
NCT04289662 is registered in ClinicalTrials.gov with Kowa Company, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-label Study to Evaluate 52 Weeks Long Term Efficacy and Safety of K-924 in Patients With Hypercholesterolemia Who Were Treated With Pitavastatin 2 mg or 4 mg.
- Lead sponsor
- Kowa Company, Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 23, 2020
- Completion date
- August 7, 2021
- Enrollment
- 110 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.